Intrinsiqq
Invivyd Inc. logo

Invivyd Inc. Quality Score

IVVD

⊜ Compare
Quality10

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-2.0x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-1.7x

Negative FCF, no valuation support

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
192.6%

Heavy dilution above 5%

Capital Structure
100/100
-$152M

Net cash position, no leverage concern

2023
$201M
$1.00B
2024
$69.0M
$1.00B
2025
$227M
$1.00B
TTM
$160M
$8.00M
CashDebt
Return on Capital
0/100
-13.0%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Invivyd (IVVD) quality: score, margins and returns

Invivyd (IVVD) scores 10/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 4 metrics each scored 0 to 100, on -192.8% operating margins and -13.0% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Invivyd (IVVD) a high-quality business?+

Invivyd scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -192.8% operating margin and a -13.0% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Invivyd's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from IVVD's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Invivyd scores well and where it falls behind.

What is Invivyd's return on invested capital (ROIC)?+

Invivyd earns about -13.0% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to IVVD's margins and growth on this scorecard to judge durability.

How profitable is Invivyd?+

Invivyd runs an operating margin of about -192.8% and a net margin of about -183.9%. Revenue has grown at roughly 110.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 30 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 14 Aug 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with IVVD

CompareIntrinsic value
CSBRChampions Oncology, Inc.
$4.83+0.00%26
FENCFennec Pharmaceuticals Inc.
$10.35-3.27%40
CHRSCoherus Biosciences Inc.
$0.85+5.46%10
RXRXRecursion Pharmaceuticals, Inc.
$3.88+5.43%25
STROSutro Biopharma, Inc.
$9.94+4.52%10
DTILPrecision Biosciences Inc.
$7.89+13.20%48
CGENCompugen Ltd.
$2.03+1.00%75
EDITEditas Medicine Inc.
$2.73+5.00%40

Held by ETFs

IVVD is in 4 US ETFs. The largest of them, with IVVD's weight in each:

Spot a number that looks wrong? Check it in IVVD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IVVD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.